2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases Grant US-11111217-B2 United States of America 07 Sep 2021
COMPOSITION FOR INCREASING EXPRESSION OF PGC-1A Application EP-3845233-A1 European Patent Office 07 Jul 2021
Method for treating neurodegenerative diseases Grant US-10966962-B2 United States of America 06 Apr 2021
2-arylbenzimidazoles as PPARGC1A activators for treating neurodegenerative diseases Grant US-10851066-B2 United States of America 01 Dec 2020